US Siluria Starts Up Methane-to-Etylene Demonstration Plant

California, US-based Siluria Technologies has held an official opening ceremony to mark the successful start-up of its methane-to-ethylene demonstration plant. The plant, co-located at a facility operated by Braskem America in La Porte, Texas, is the world's first large-scale production of ethylene directly from natural gas based on the oxidative coupling of methane (OCM).

The demonstration unit is the final scale-up of its OCM process technology and paves the way for Siluria to build commercial-scale plants in 2017-2018. Ed Dineen, Siluria's CEO, commented: "This revolutionary breakthrough has the potential to shift the foundation of the hydrocarbon economy by using abundant natural gas to produce high-value chemicals and fuels. We are well positioned with our commercial and engineering partners to now move quickly to full commercialization of our proprietary technologies."

Siluria has partnered with engineering firms to validate and commercialize the technology in specific projects within the ethylene, gas processing and oil refining sectors. It has previously announced a partnership with Germany's Linde Group to offer licenses to the global ethylene industry.

A second process technology has also been developed to convert ethylene to liquids (ETL) to produce tailored products such as gasoline and other high-value hydrocarbon liquids. Siluria has been using ETL technology to produce gasoline at a pilot facility in Hayward, California, since November 2013.

The company said the combination of its OCM and ETL technologies provide an entirely new platform for energy companies to add significant value uplift to their lowest value products, such as methane and ethane.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.